Bionano Genomics Analyst Ratings
Strong Performance and Strategic Initiatives Underpin Buy Rating for BioNano Genomics
BioNano Genomics (BNGO) Gets a Buy From Scotiabank
Bionano Genomics Analyst Ratings
A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk
Analysts Are Bullish on Top Healthcare Stocks: BioNano Genomics (BNGO), Legend Biotech (LEGN)
Maxim Group Remains a Hold on BioNano Genomics (BNGO)
BioNano Genomics (BNGO) Gets a Buy From BTIG
BTIG Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and Ascendis Pharma (ASND)
Bionano Genomics Analyst Ratings
Scotiabank Remains a Buy on BioNano Genomics (BNGO)
Maxim Group Adjusts Bionano Genomics Price Target to $6 From $30, Maintains Buy Rating
Bionano Genomics Analyst Ratings
BTIG Remains a Buy on BioNano Genomics (BNGO)
BTIG Adjusts Price Target on Bionano Genomics to $2 From $3, Maintains Buy Rating
BTIG Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
BioNano Genomics (BNGO) Receives a Buy From Maxim Group
Analysts' Top Healthcare Picks: Outlook Therapeutics (OTLK), BioNano Genomics (BNGO)
Maxim Group Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
No Data